CIK 0001563665
- Non-accelerated filer
- Smaller reporting company
Harvard Apparatus Regenerative Technology, Inc.
Sign in to watch- Ticker
- HRGN
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455210462
- Phone
- +1 774-233-7300
- Business address
- 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON, MA, 01746
- Former names
- Biostage, Inc.
- Open-market buys, last 90 days
- $394,459
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$394,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 1 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-11-19 | McGorry James Joseph President and CEO | Purchase | +10,000 | $1.79 | $18K | 71,300 |
| 2015-11-18 | McNaughton Thomas Chief Financial Officer | Purchase | +10,000 | $1.56 | $16K | 191,128 |
| 2015-11-17 | McNaughton Thomas Chief Financial Officer | Purchase | +15,000 | $1.32 | $20K | 181,128 |
| 2015-11-17 | GREEN DAVID Director | Purchase | +25,000 | $1.34 | $34K | 313,259 |
| 2015-09-18 | LaFrancesca Saverio Chief Medical Officer | Purchase | +5,000 | $1.29 | $6K | 29,498 |
| 2015-09-18 | LaFrancesca Saverio Chief Medical Officer | Purchase | +4,500 | $1.28 | $6K | 33,998 |
| 2015-08-31 | McNaughton Thomas Chief Financial Officer | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2015-08-31 | LaFrancesca Saverio Chief Medical Officer | Grant or award · Stock option (right to buy) | +160,000 | 160,000 | ||
| 2015-08-28 | LaFrancesca Saverio Chief Medical Officer | Purchase | +2,500 | $0.96 | $2K | 24,498 |
| 2015-08-28 | LaFrancesca Saverio Chief Medical Officer | Purchase | +2,500 | $0.96 | $2K | 14,214 |
| 2015-08-26 | McNaughton Thomas Chief Financial Officer | Purchase | +10,000 | $0.88 | $9K | 166,128 |
| 2015-08-24 | KENNEDY JOHN F Director | Purchase | +12,000 | $0.83 | $10K | 26,724 |
| 2015-08-21 | McNaughton Thomas Chief Financial Officer | Purchase | +25,000 | $0.76 | $19K | 156,128 |
| 2015-08-21 | McGorry James Joseph President and CEO | Purchase | +26,300 | $0.75 | $20K | 61,300 |
| 2015-08-20 | McGorry James Joseph President and CEO | Purchase | +5,000 | $0.66 | $3K | 35,000 |
| 2015-08-19 | McNaughton Thomas Chief Financial Officer | Purchase | +75,000 | $0.62 | $47K | 131,128 |
| 2015-07-06 | McGorry James Joseph President and CEO | Grant or award · Stock option (right to buy) | +671,400 | 671,400 | ||
| 2015-06-30 | LaFrancesca Saverio Chief Medical Officer | Other acquisition | +10,284 | $1.22 | $13K | 21,998 |
| 2015-06-04 | KENNEDY JOHN F Director | Purchase | +1,000 | $2.13 | $2K | 14,724 |
| 2015-06-03 | GREEN DAVID Director | Purchase | +23,400 | $1.98 | $46K | 288,259 |
Page 14 of 18 · 345 trades